On March 14, 2025, the U.S. Department of Health and Human Services (HHS) issued a revised Statement of Organization for the Office of the General Counsel (HHS-OGC).1 Changes include a return to an organizational structure more like the early days of the first Trump administration for the lawyers advising the Food and Drug Administration (FDA), as
Latest Post
More Posts
CMS Seeks Comments on Proposed Guidance Addressing Study Protocols That Use Real-World Data
CMS Proposes Artificial Intelligence Limits and Utilization Management Guardrails for Medicare Advantage
Deal Outlook for 2024 Includes GLP-1 Investments, APAC M&A, and More Spinoffs
Forthcoming HHS Regulatory Actions and Opportunities Relevant for Pharmaceutical Manufacturers for the Rest of this Year and Next
HHS-OIG Rejects Calls for New Safe Harbors for Financial Support to Patients Enrolled in Clinical Trials
Digital Health and Artificial Intelligence: New Developments From President Biden’s Executive Order
Five Tips for Bringing a Complex Digital Health Product to Market
Impact Of Inflation Reduction Act On Drug Development For U.S. Market
Subscribe: Subscribe via RSS
Blogs
Firm/Org